Minimal Effective Concentration (EC90) of Ropivacaine

NCT03688269 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Anesthesia, Conduction
Ropivacaine
Dexamethasone
Axillary Brachial Plexus Block

Interventions

DRUG: Intravenous dexamethasone
DRUG: Intravenous saline
DRUG: Perineural ropivacaine

Sponsor

Centre Hospitalier Universitaire de Besancon